title: [Intracavernous injections and new medical treatments of impotence].
abstract: Intracavernous injections (IIC) of vasoactives drugs is the most frequent treatment of erectile dysfunction (ED). Indications, technique and immediate as well as long term results are presented here. A retrospective quantified study of the follow up at 5 years of use shows that 94% of the patients who still use the treatment are satisfied, comparing with 48% who have stopped, and 21% who have never taken it. The overall rate of patients cured (i.e.; having a normal sexual life, without using the treatment) is 26.6%. The drop out rate linked to the treatment itself is 25%. Complications are seldom and benign: 7% of prolonged erection episodes, all solved by a medical regimen, mostly administered by the patient itself; nodules are present in 3% of the patients or do not interfere with the efficacy of the treatment; they are 1.6% Peyronie's like plaques. Perspectives opened by new treatments such as the Muse system and oral therapy by sildenafil or apomorphine are discussed.
authors.affiliation: CETI, Paris, France.
authors.forename: R
authors.initials: R
authors.lastname: Virag
mesh_terms: D000284:Administration, Oral; D000527:Alprostadil / Q000008:administration & dosage; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D007267:Injections; D008297:Male; D014665:Vasodilator Agents / Q000008:administration & dosage
chemical_list: D014665:Vasodilator Agents; D000527:Alprostadil